Mucosal IL13RA2 expression predicts nonresponse to anti‐TNF therapy in Crohn's diseaseBram Verstockt, Christine Breynaert, Marc Ferrante et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 72
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype EquilibriumBrecht Creyns, Christine Breynaert, Inge Jacobs et al.|Frontiers in Immunology|2020Cited by 40
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel DiseaseBram Verstockt, Christine Breynaert, Clémentine Perrier et al.|Frontiers in Immunology|2018Cited by 24
DOP70 An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's diseaseBram Verstockt, Marc Ferrante, P Sudahakar et al.|Journal of Crohn s and Colitis|2019Cited by 12